- Home
- PMVP vs IAE Comparison
PMVP vs IAE Comparison
Compare PMVP & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- IAE
- Stock Information
- Founded
- PMVP 2013
- IAE 2007
- Country
- PMVP United States
- IAE United States
- Employees
- PMVP N/A
- IAE N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- IAE Trusts Except Educational Religious and Charitable
- Sector
- PMVP Health Care
- IAE Finance
- Exchange
- PMVP Nasdaq
- IAE Nasdaq
- Market Cap
- PMVP 77.4M
- IAE 74.3M
- IPO Year
- PMVP 2020
- IAE N/A
- Fundamental
- Price
- PMVP $1.14
- IAE $7.29
- Analyst Decision
- PMVP Strong Buy
- IAE
- Analyst Count
- PMVP 1
- IAE 0
- Target Price
- PMVP $5.00
- IAE N/A
- AVG Volume (30 Days)
- PMVP 2.6M
- IAE 46.3K
- Earning Date
- PMVP 11-06-2025
- IAE 01-01-0001
- Dividend Yield
- PMVP N/A
- IAE 10.21%
- EPS Growth
- PMVP N/A
- IAE N/A
- EPS
- PMVP N/A
- IAE N/A
- Revenue
- PMVP N/A
- IAE N/A
- Revenue This Year
- PMVP N/A
- IAE N/A
- Revenue Next Year
- PMVP N/A
- IAE N/A
- P/E Ratio
- PMVP N/A
- IAE N/A
- Revenue Growth
- PMVP N/A
- IAE N/A
- 52 Week Low
- PMVP $0.81
- IAE $5.31
- 52 Week High
- PMVP $1.84
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- PMVP 36.32
- IAE 62.59
- Support Level
- PMVP $1.19
- IAE $7.22
- Resistance Level
- PMVP $1.40
- IAE $7.25
- Average True Range (ATR)
- PMVP 0.16
- IAE 0.07
- MACD
- PMVP -0.04
- IAE 0.00
- Stochastic Oscillator
- PMVP 1.41
- IAE 81.86
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.